Article contents
Travel-screening documentation to enable the “Identify–Isolate–Inform” framework for emerging infectious diseases: It’s all in the details
Published online by Cambridge University Press: 27 August 2020
Abstract
The early phase of the coronavirus disease 2019 (COVID-19) pandemic and ongoing efforts for mitigation underscore the importance of universal travel and symptom screening. We analyzed adherence to documentation of travel and symptom screening through a travel navigator tool with clinical decision support to identify patients at risk for Middle East Respiratory Syndrome.
- Type
- Concise Communication
- Information
- Copyright
- © 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.
Footnotes
PREVIOUS PRESENTATION: A preliminary analysis of this data was submitted as a Poster Abstract for the Society for Healthcare Epidemiology of America (SHEA) Sixth International Conference on Healthcare Associated Infections and will be published in a supplemental issue of SHEA’s scientific journal, Infection Control and Hospital Epidemiology (ICHE).
References
- 3
- Cited by